Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination
- PMID: 26436611
- PMCID: PMC4688454
- DOI: 10.1001/jama.2015.12160
Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination
Abstract
Importance: Few studies have evaluated the relationship between influenza vaccination and pneumonia, a serious complication of influenza infection.
Objective: To assess the association between influenza vaccination status and hospitalization for community-acquired laboratory-confirmed influenza pneumonia.
Design, setting, and participants: The Etiology of Pneumonia in the Community (EPIC) study was a prospective observational multicenter study of hospitalizations for community-acquired pneumonia conducted from January 2010 through June 2012 at 4 US sites. In this case-control study, we used EPIC data from patients 6 months or older with laboratory-confirmed influenza infection and verified vaccination status during the influenza seasons and excluded patients with recent hospitalization, from chronic care residential facilities, and with severe immunosuppression. Logistic regression was used to calculate odds ratios, comparing the odds of vaccination between influenza-positive (case) and influenza-negative (control) patients with pneumonia, controlling for demographics, comorbidities, season, study site, and timing of disease onset. Vaccine effectiveness was estimated as (1 - adjusted odds ratio) × 100%.
Exposure: Influenza vaccination, verified through record review.
Main outcomes and measures: Influenza pneumonia, confirmed by real-time reverse-transcription polymerase chain reaction performed on nasal/oropharyngeal swabs.
Results: Overall, 2767 patients hospitalized for pneumonia were eligible for the study; 162 (5.9%) had laboratory-confirmed influenza. Twenty-eight of 162 cases (17%) with influenza-associated pneumonia and 766 of 2605 controls (29%) with influenza-negative pneumonia had been vaccinated. The adjusted odds ratio of prior influenza vaccination between cases and controls was 0.43 (95% CI, 0.28-0.68; estimated vaccine effectiveness, 56.7%; 95% CI, 31.9%-72.5%).
Conclusions and relevance: Among children and adults hospitalized with community-acquired pneumonia, those with laboratory-confirmed influenza-associated pneumonia, compared with those with pneumonia not associated with influenza, had lower odds of having received influenza vaccination.
Figures
Similar articles
-
Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.Clin Infect Dis. 2013 Jul;57(2):167-75. doi: 10.1093/cid/cit194. Epub 2013 Mar 26. Clin Infect Dis. 2013. PMID: 23532475
-
Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.Clin Infect Dis. 2016 Nov 15;63(10):1304-1311. doi: 10.1093/cid/ciw512. Epub 2016 Aug 2. Clin Infect Dis. 2016. PMID: 27486114
-
Community acquired influenza requiring hospitalization: vaccine status is unrelated to morbidity in children with cancer.Pediatr Blood Cancer. 2010 Jan;54(1):79-82. doi: 10.1002/pbc.22228. Pediatr Blood Cancer. 2010. PMID: 19743304 Clinical Trial.
-
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.Vaccine. 2021 Jun 23;39(28):3678-3695. doi: 10.1016/j.vaccine.2021.05.011. Epub 2021 Jun 2. Vaccine. 2021. PMID: 34090700 Review.
-
Targeted vaccine selection in influenza vaccination.Dtsch Arztebl Int. 2013 Nov 22;110(47):793-8. doi: 10.3238/arztebl.2013.0793. Dtsch Arztebl Int. 2013. PMID: 24314622 Free PMC article. Review.
Cited by
-
Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group.Vaccines (Basel). 2024 Apr 16;12(4):420. doi: 10.3390/vaccines12040420. Vaccines (Basel). 2024. PMID: 38675802 Free PMC article. Review.
-
SARS-CoV-2 vaccination and risk of infectious diseases in hospitalized older patients.Eur Geriatr Med. 2024 Apr;15(2):509-517. doi: 10.1007/s41999-023-00902-x. Epub 2024 Jan 5. Eur Geriatr Med. 2024. PMID: 38182805
-
Epidemiologic transition and the double burden of disease in Ghana: What do we know at the neighborhood level?PLoS One. 2023 Feb 24;18(2):e0281639. doi: 10.1371/journal.pone.0281639. eCollection 2023. PLoS One. 2023. PMID: 36827236 Free PMC article.
-
Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications.Vaccines (Basel). 2022 Oct 19;10(10):1752. doi: 10.3390/vaccines10101752. Vaccines (Basel). 2022. PMID: 36298617 Free PMC article.
-
Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine.JAMA Netw Open. 2022 Mar 1;5(3):e221111. doi: 10.1001/jamanetworkopen.2022.1111. JAMA Netw Open. 2022. PMID: 35302634 Free PMC article.
References
-
- Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1–62. - PubMed
-
- Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685–696. - PubMed
-
- Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
